Alle Fälle anzeigen
UPC APP 11372/2025
—·EP2401365: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION
- Verfahrensdetails
- Status—VerfahrensartVerfahrensantragKategorieVerfahrensführungsanordnungen
- Parteien
- Beklagte
- BioNTech SE
- BioNTech Manufacturing GmbH
- BioNTech Manufacturing Marburg GmbH
- BioNTech Innovative Manufacturing Services GmbH
- BioNTech Europe GmbH
- Pfizer Manufacturing Belgium NV
- Pfizer SAS
- Pfizer AB
- Pfizer, Inc.
Vertreter: Christine Kanz (Hoyng Rokh Monegier); Tobias J. Hessel (Clifford Chance) - Division
- Munich LD
- Richter
- Andras Kupecz · Judge-rapporteur
- Technology
- Biotechnology
- Sprache
- —
- Erste Entscheidung
- 3. Apr. 2025
Entscheidungen
- 2025-04-03Procedural Order
Munich Local Division order on BioNTech/Pfizer's application under R. 190 RoP for production of detailed materials, methods and raw data underlying an expert report (Exhibit VB 6) submitted by Promosome LLC (claimant) in mRNA patent infringement proceedings. The order addresses what supporting data must be disclosed when an expert report is filed as evidence.
Rechtsfragen:Production of evidence (R. 190 RoP)Expert report materials and raw data disclosuremRNA technology patent infringement
Dokumente
- D594C630588987BAD4B3DFA685E7EFF1_en.pdf2025-04-03ENGLISH